Discovery

Evotec

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

GERMANY Germany

Post An Enquiry

Virtual Booth

World Dairy Expo

Participation Not Confirmed

Update your events

Evotec and Centogene Expand Collaboration into Gaucher Disease

Lead Product(s): Induced pluripotent stem cell

Therapeutic Area: Genetic Disease Product Name: Undisclosed

Highest Development Status: Discovery Product Type: Cell and Gene therapy

Partner/Sponsor/Collaborator: Centogene

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Expanded Collaboration August 20, 2020

Details:

The collaboration brings together Evotec’s leading induced pluripotent stem cell platform and broad drug discovery and development capabilities with CENTOGENE’s global proprietary rare disease platform, including iPSC lines, to address the needs of this orphan drug indication.

Gero

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Post An Enquiry

Virtual Booth

World Dairy Expo

Participation Not Confirmed

Update your events

Gero, a Singapore-based Biotech Startup raises $2.2M in Series A Funding

Lead Product(s): Undisclosed

Therapeutic Area: Genetic Disease Product Name: Undisclosed

Highest Development Status: Discovery Product Type: Undisclosed

Partner/Sponsor/Collaborator: Bulba Ventures

Deal Size: $2.2 million Upfront Cash: Undisclosed

Deal Type: Series A Financing August 05, 2020

Details:

The financing brought the total capital raised by the firm to more than $7.5M which will be invested in Gero's proprietary AI/ML platforms for new drugs development for aging and other complicated disorders.

Light Chain Bioscience

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Switzerland

Post An Enquiry

Virtual Booth

World Dairy Expo

Participation Not Confirmed

Update your events

Novimmune unit nabs Takeda milestone payment for hemophilia work

Lead Product(s): Bispecific antibodies

Therapeutic Area: Genetic Disease Product Name: Undisclosed

Highest Development Status: Discovery Product Type: Large molecule

Partner/Sponsor/Collaborator: Takeda Pharmaceutical

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Collaboration February 13, 2020

Details:

The milestone was achieved upon the successful completion of the discovery phase and designation by Takeda of undisclosed bispecific antibodies with approval to advance to IND-enabling studies.

Find

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

Product Type

Companies

Evotec

Evotec and Centogene Expand Collaboration into Gaucher Disease

Gero

Gero, a Singapore-based Biotech Startup raises $2.2M in Series A Funding

Light Chain Bioscience

Novimmune unit nabs Takeda milestone payment for hemophilia work